• A Cancer
      Free World
  • Company
    • About us
    • Strategic Collaboration
    • Founders
    • Board of Directors & Advisors
    • Management
    • Medical Advisory Board & Strategic Collaboration
    • Inventors
    • Law Firms
  • Technology
    • TIL Therapies
    • Why is TZ 102 so important to T-cell (TIL) Therapies:
    • TZ102 TIL Therapy Advantages
  • Products
  • Pipeline
  • Publications

Publications

  • date
  • title
  • Download PDF
  • January 15,2019
    Fucosylation Enhances the Efficacy of Adoptively Transferred Antigen-Specific Cytotoxic T Lymphocytes
  • October 19,2019
    Glycoengineering of chimeric antigen receptor (CAR) T-cells to enforce E-selectin binding
  • May 5,2015
    Therapeutic approaches to enhance natural killer cell cytotoxicity against cancer: the force awakens
  • November 27,1995
    Prognostic Value of Tumor Infiltrating Lymphocytes in the Vertical Growth Phase of Primary Cutaneous MelanomaJanuary 10,2021
  • January 10,2021
    Cellular Therapy for the Treatment of Solid Tumors
  • April 5,2021
    Adoptive T cell Therapy for Solid Tumors: Pathway to Personalized Standard of Care
  • May 8,2021
    Adoptive Cellular Therapy for Solid Tumors
  • March 4, 2020
    Characteristics of Tumor-Infiltrating Lymphocytes Prior to and During Immune Checkpoint Inhibitor Therapy
  • July 9, 2021
    ACT Up TIL Now: The Evolution of Tumor-Infiltrating Lymphocytes in Adoptive Cell Therapy for the Treatment of Solid Tumors
  • June 21, 2021
    Adoptive cellular therapy in solid tumor malignancies: review of the literature and challenges ahead
  • June 2013
    Mining Exomic Sequencing Data to Identify Mutated Antigens Recognized by Adoptively Transferred Tumor-reactive T cells
  • April 3, 2015
    Adoptive cell transfer as personalized immunotherapy for human cancer
  • June 30, 2021
    T-cell receptor-based therapy: an innovative therapeutic approach for solid tumors
  • Dec 8, 2016
    T-Cell Transfer Therapy Targeting Mutant KRAS in Cancer
  • June 11, 2021
    Perspective of tumor-infiltrating lymphocyte treatment in solid tumors
  • July 22, 2013
    Fucosyltransferase VII improves the function of selectin ligands on cord blood hematopoietic
view more

CONTACT US

  • 2100 Palomar Airport Road Suite 214-19 Carlsbad, CA 92011
  • info@targazyme.com

QUICK LINKS

  • Home
  • Technology
  • Products
  • Pipeline
  • Careers
  • Contact Us

Categories

  • Press Releases
  • Publications
  • Uncategorized

© ,Targazyme. All Rights Reserved.